Cardiac transplantation following ACORN CorCap device implantation

Schroder, Jacob N.; Lima, Brian; Rogers, Joseph G.; Milano, Carmelo A.
May 2006
European Journal of Cardio-Thoracic Surgery;May2006, Vol. 29 Issue 5, p848
Academic Journal
Abstract: Passive ventricular restraint devices, such as the ACORN CorCap, have been introduced as a potential therapy for congestive heart failure (CHF). These mesh devices act as a mechanical support for the dilated heart. Due to incorporation of the device to the epicardium, concerns about the feasibility of reoperation following CorCap placement have been raised. This case illustrates that although technically challenging, reoperation for heart transplantation after CorCap implantation is feasible and safe.


Related Articles

  • Choosing Death. Roubein, Rachel // National Journal;12/6/2014, p1 

    The article focuses on several devices to support a heart failure such as left ventricular assist device (LVAD) with reference to the case of a heart patient Jim Reales who chose death and not the device. Topics discussed include Extracorporeal Membrane Oxygenation machine supporting failure of...

  • Heterotopic heart transplantation: where do we stand? Flécher, Erwan; Fouquet, Olivier; Ruggieri, Vito Giovanni; Chabanne, Céline; Lelong, Bernard; Leguerrier, Alain // European Journal of Cardio-Thoracic Surgery;Aug2013, Vol. 44 Issue 2, p201 

    Orthotopic heart transplantation (OHT) is a well established and commonly utilized procedure for end-stage heart failure patients. Heterotopic heart transplantation (HHT) is a surgical procedure that allows the graft to be connected to the native heart in a parallel fashion. The main advantage...

  • A stranger's heart. Burns, Susan // Sarasota Magazine;Summer98, Vol. 20 Issue 7, p28 

    Features Nels Gustafson, a retired electrical engineer who undergone a heart transplant. How he discovered that he is suffering from severe congestive heart failure; Symptoms of the disease; How the operation was done; Success of the operation.

  • Lowering readmission rates in patients with CHF.  // American Family Physician;4/1/1996, Vol. 53 Issue 5, p1823 

    Focuses on lowering the readmission rates for patients with congestive heart failure. Percentage of readmission; What would help lower the rate; Study from M.W. Rich and others in the New England Journal of Medicine 1995; Methodology of study; Average cost of intervention per patient; Authors'...

  • Heart Failure Patients' Perceptions and Use of Technology to Manage Disease Symptoms. Hall, Amanda K.; Dodd, Virginia; Harris, Amy; McArthur, Kara; Dacso, Clifford; Colton, Lara M. // Telemedicine & e-Health;Apr2014, Vol. 20 Issue 4, p324 

    Background: Technology use for symptom management is beneficial for both patients and physicians. Widespread acceptance of technology use in healthcare fuels continued development of technology with ever-increasing sophistication. Although acceptance of technology use in healthcare by medical...

  • Resistencia a Diuréticos de Asa en el Tratamiento de Pacientes con Insuficiencia Cardiaca Descompensada y Síndrome Cardiorenal. Fernández, Hungría; Campos, Damián; Villalobos, Jacobo // Informe Medico;2014, Vol. 16 Issue 3, p88 

    High ceiling diuretics are the cornerstone in the treatment of patients with congestive heart failure and cardiorenal syndrome. Loop diuretics are recommended by the ACCF and AHA as initial treatment, during acute exacerbation of congestive heart failure and also in non-hospitalized patients...

  • Diagnostic value of pleural effusion ischaemia-modified albumin in patients with cardiac failure. Ozsu, Savas; Gulsoy, Ayhan; Karahan, S. Caner; Mentese, Ahmet; Nuhoglu, Irfan; Ozlu, Tevfik // Annals of Clinical Biochemistry;Jan2011, Vol. 48 Issue 1, p45 

    Background: Ischaemia-modified albumin (IMA) is a relatively new marker of ischaemia. IMA has not been studied previously in pleural effusions due to congestive heart failure (CHF). The aim of our study was to assess the diagnostic value of IMA in the pleural fluid (PF) and serum for the...

  • N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure ... Maeder, Micha T.; Rickenbacher, Peter; Rickli, Hans; Abbühl, Heidi; Gutmann, Marc; Erne, Paul; Vuilliomenet, André; Peter, Martin; Pfisterer, Matthias; Brunner-La Rocca, Hans-Peter // European Journal of Heart Failure; 

    Aims To assess the effects of an NT-proBNP-guided medical management on 18-month outcomes in patients with heart failure (HF) and preserved LVEF ( HFpEF). Methods and results Patients with HFpEF (LVEF >45%; n = 123) and HF with reduced LVEF (HFrEF; LVEF ≤45%; n = 499) with age ≥60...

  • Left ventricular or biventricular pacing? Single or multielectrode leads? An implanter's viewpoint. Sethi, Kamal; Sethi, Kabir; Chutani, Surendra // Journal of Interventional Cardiac Electrophysiology;Sep2014, Vol. 40 Issue 3, p255 

    The author reflects on the effectiveness of left ventricular (LV) or biventricular pacing during the cardiac resynchronization therapy (CRT). Topics discussed include use of CRT in the treatment of patients of congestive heart failure with ventricular conduction delay, haemodynamic effect of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics